We are live on ! Find out more
PM

Ponoi Management Portfolio holdings

AUM $73.2M
1-Year Est. Return 23.44%
This Fund
S&P 500
This Quarter Est. Return
-0.92%
1 Year Est. Return
-23.44%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$170M
AUM Growth
-$4.77M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
1 quarter
Top 10 Avg Time Held
1 quarter
Top 20 Avg Time Held
1 quarter

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CNST
1
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$44M 25.87%
1,880,623
– –
2020 Q4
1 quarter
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$37.8M 22.21%
1,298,908
– –
2020 Q4
1 quarter
RAPT icon
3
DELISTED
RAPT Therapeutics
RAPT
$35.5M 20.88%
199,927
– –
2020 Q4
1 quarter
RVMD icon
4
Revolution Medicines
RVMD
$41.5B
$31.4M 18.49%
685,011
– –
2020 Q4
1 quarter
NRIX icon
5
Nurix Therapeutics
NRIX
$2.29B
$21.3M 12.55%
686,274
– –
2020 Q4
1 quarter

Similar funds

Ponoi Management's Q1 2021 Portfolio in Review

As of Q1 2021, Ponoi Management held 5 positions worth $170M, down 2.7% from $175M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2021: portfolio turnover was 0%. Ponoi Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Ponoi Management's ten largest holdings make up 100% of its $170M portfolio in Q1 2021.
  • Ponoi Management opened 0 new positions and closed 0 in Q1 2021.
  • Ponoi Management's portfolio value fell 2.7% quarter-over-quarter to $170M.

Based on Ponoi Management's 13F filing for Q1 2021, filed 17 May 2021.